ArticleForum for health economics & policy2014
Medicare Reimbursement Reform for Provider Visits and Health Outcomes in Patients on Hemodialysis.
Article in Forum for health economics & policy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Utilization of Telemedicine for Patients Receiving In-Center Hemodialysis in the United States.Journal of the American Society of Nephrology : JASN · 2025Article
- Payment systems for dialysis and their effects: a scoping review.BMC health services research · 2023Article
- Evaluating the Evidence behind Policy Mandates in US Dialysis Care.Journal of the American Society of Nephrology : JASN · 2018Article
- Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2017Article
- Effects of physician payment reform on provision of home dialysis.The American journal of managed care · 2016Article
- Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis.Journal of the American Society of Nephrology : JASN · 2015Article
- Provider visit frequency and vascular access interventions in hemodialysis.Clinical journal of the American Society of Nephrology : CJASN · 2015Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The relation between the quantity of many healthcare services delivered and health outcomes is uncertain. In January 2004, the Centers for Medicare and Medicaid Services introduced a tiered fee-for-service system for patients on hemodialysis, creating an incentive for providers to see patients more frequently. We analyzed the effect of this change on patient mortality, transplant wait-listing, and costs. While mortality rates for Medicare beneficiaries on hemodialysis declined after reimbursement reform, mortality declined more - or was no different - among patients whose providers were not affected by the economic incentive. Similarly, improved placement of patients on the kidney transplant waitlist was no different among patients whose providers were not affected by the economic incentive; payments for dialysis visits increased 13.7% in the year following reform. The payment system designed to increase provider visits to hemodialysis patients increased Medicare costs with no evidence of a benefit on survival or kidney transplant listing.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.